PX-69

N/A

Report date: 2024/05/31 09:49:15
NME

Base Information

Drug NamePX-69
Drug Alias NamePX-69LABP-69LABP 69
ClassificationSmall molecules
Mechanisms of ActionPlexin Domain Containing 2 agonists
TargetsPlexin Domain Containing 2
Therapy Area/IndicationsDiabetic NephropathiesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLandos Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesLandos Biopharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetic NephropathiesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A